大葉大學圖書館 |

New weapons to control bacterial growth[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	579.3
書名/作者:	New weapons to control bacterial growth/ edited by Tomas G. Villa, Miguel Vinas.
其他作者:	Villa, Tomas G.
出版者:	Cham : : Springer International Publishing :, 2016.
面頁冊數:	vi, 556 p. : : ill. (some col.), digital ;; 24 cm.
Contained By:	Springer eBooks
標題:	Bacterial growth - Control.
標題:	Life Sciences.
標題:	Microbiology.
標題:	Medical Microbiology.
標題:	Infectious Diseases.
ISBN:	9783319283685
ISBN:	9783319283661
內容註:	Bacteriocins -- Control of bacterial growth through RNA degradation -- Control of Pathogenic Clostridia -- DNA-synthesizing enzymes as antibacterial targets -- Inhibition of bacterial efflux pump activity as a way to control microbial growth -- Bacterial protease as targets to control bacterial growth -- Quorum sensing and competence stimulation as targets for antimicrobial chemotherapy -- Transcriptomics as a tool to finding new antibacterial targets -- The case of Lipid II: the Achille's heel of bacteria -- Microbiome Control in the Prevention and Early Management of Cancer -- Targets against Helicobacter pylori and other tumor-producing bacteria -- Intestinal Microbiota: First barrier against gut-affecting pathogens -- Fecal matter implantation as a way to fight diarrhea-causing microorganisms -- Different approaches for searching new microbial antibiotics controlling bacterial growth -- Synthetic peptides as antimicrobials -- The use of nanoparticles for antimicrobials delivery -- Predation and competition: bacteriophages and bacteria as antimicrobial agents.
摘要、提要註:	Written by specialists in the different fields, this book presents new perspectives and insights into strategies and weapons to fight microbial infections. It also reviews the "state of the art" of alternative treatment approaches and new therapeutic agents to deal with infections caused by multidrug-resistant microorganisms. In an era of accumulated resistance to current antibiotics, it is vital that this is undertaken without further delay. Aspects discussed include the control of RNA synthesis, the use of bacteriocins or enzybiotics (bacteriophages or purified lysins), the specific control of pathogenic clostridia, the design of new drugs affecting DNA synthesis in bacteria, the use of fecal-matter transplant strategies, the specific control of quorum sensing responses in bacteria, the use of new peptides as antibiotics and new ways to control bacteria that cause cancer, such as Helicobacter pylori cancers.
電子資源:	http://dx.doi.org/10.1007/978-3-319-28368-5

New weapons to control bacterial growth[electronic resource] /
New weapons to control bacterial growth[electronic resource] /edited by Tomas G. Villa, Miguel Vinas. - Cham :Springer International Publishing :2016. - vi, 556 p. :ill. (some col.), digital ;24 cm.

Bacteriocins -- Control of bacterial growth through RNA degradation -- Control of Pathogenic Clostridia -- DNA-synthesizing enzymes as antibacterial targets -- Inhibition of bacterial efflux pump activity as a way to control microbial growth -- Bacterial protease as targets to control bacterial growth -- Quorum sensing and competence stimulation as targets for antimicrobial chemotherapy -- Transcriptomics as a tool to finding new antibacterial targets -- The case of Lipid II: the Achille's heel of bacteria -- Microbiome Control in the Prevention and Early Management of Cancer -- Targets against Helicobacter pylori and other tumor-producing bacteria -- Intestinal Microbiota: First barrier against gut-affecting pathogens -- Fecal matter implantation as a way to fight diarrhea-causing microorganisms -- Different approaches for searching new microbial antibiotics controlling bacterial growth -- Synthetic peptides as antimicrobials -- The use of nanoparticles for antimicrobials delivery -- Predation and competition: bacteriophages and bacteria as antimicrobial agents.

Written by specialists in the different fields, this book presents new perspectives and insights into strategies and weapons to fight microbial infections. It also reviews the "state of the art" of alternative treatment approaches and new therapeutic agents to deal with infections caused by multidrug-resistant microorganisms. In an era of accumulated resistance to current antibiotics, it is vital that this is undertaken without further delay. Aspects discussed include the control of RNA synthesis, the use of bacteriocins or enzybiotics (bacteriophages or purified lysins), the specific control of pathogenic clostridia, the design of new drugs affecting DNA synthesis in bacteria, the use of fecal-matter transplant strategies, the specific control of quorum sensing responses in bacteria, the use of new peptides as antibiotics and new ways to control bacteria that cause cancer, such as Helicobacter pylori cancers.

ISBN: 9783319283685

Standard No.: 10.1007/978-3-319-28368-5doiSubjects--Topical Terms:

639099
Bacterial growth
--Control.

LC Class. No.: QR84.5

Dewey Class. No.: 579.3

New weapons to control bacterial growth[electronic resource] /
LDR:02953nam a2200313 a 4500 001 446444
003 DE-He213
005 20160909091937.0
006 m d
007 cr nn 008maaau
008 161201s2016 gw s 0 eng d
020 $a 9783319283685 $q (electronic bk.)
020 $a 9783319283661 $q (paper)
024 7 $a 10.1007/978-3-319-28368-5 $2 doi
035 $a 978-3-319-28368-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QR84.5
072 7 $a PSG $2 bicssc
072 7 $a SCI045000 $2 bisacsh
082 0 4 $a 579.3 $2 23
090 $a QR84.5 $b .N532 2016
245 0 0 $a New weapons to control bacterial growth $h [electronic resource] / $c edited by Tomas G. Villa, Miguel Vinas.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a vi, 556 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Bacteriocins -- Control of bacterial growth through RNA degradation -- Control of Pathogenic Clostridia -- DNA-synthesizing enzymes as antibacterial targets -- Inhibition of bacterial efflux pump activity as a way to control microbial growth -- Bacterial protease as targets to control bacterial growth -- Quorum sensing and competence stimulation as targets for antimicrobial chemotherapy -- Transcriptomics as a tool to finding new antibacterial targets -- The case of Lipid II: the Achille's heel of bacteria -- Microbiome Control in the Prevention and Early Management of Cancer -- Targets against Helicobacter pylori and other tumor-producing bacteria -- Intestinal Microbiota: First barrier against gut-affecting pathogens -- Fecal matter implantation as a way to fight diarrhea-causing microorganisms -- Different approaches for searching new microbial antibiotics controlling bacterial growth -- Synthetic peptides as antimicrobials -- The use of nanoparticles for antimicrobials delivery -- Predation and competition: bacteriophages and bacteria as antimicrobial agents.
520 $a Written by specialists in the different fields, this book presents new perspectives and insights into strategies and weapons to fight microbial infections. It also reviews the "state of the art" of alternative treatment approaches and new therapeutic agents to deal with infections caused by multidrug-resistant microorganisms. In an era of accumulated resistance to current antibiotics, it is vital that this is undertaken without further delay. Aspects discussed include the control of RNA synthesis, the use of bacteriocins or enzybiotics (bacteriophages or purified lysins), the specific control of pathogenic clostridia, the design of new drugs affecting DNA synthesis in bacteria, the use of fecal-matter transplant strategies, the specific control of quorum sensing responses in bacteria, the use of new peptides as antibiotics and new ways to control bacteria that cause cancer, such as Helicobacter pylori cancers.
650 0 $a Bacterial growth $x Control. $3 639099
650 1 4 $a Life Sciences. $3 463509
650 2 4 $a Microbiology. $3 182563
650 2 4 $a Medical Microbiology. $3 463660
650 2 4 $a Infectious Diseases. $3 463456
700 1 $a Villa, Tomas G. $3 611653
700 1 $a Vinas, Miguel. $3 639098
710 2 $a SpringerLink (Online service) $3 463450
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-28368-5
950 $a Biomedical and Life Sciences (Springer-11642)